EMBC
$8.89-0.23 (-2.52%)
Market ClosedAs of Mar 20, 8:00 PM UTC
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally.
Recent News
Embecta agrees to acquire Owen Mumford
The acquisition brings in the Aidaptus auto-injector platform and related intellectual property.
Embecta to buy Owen Mumford for up to $201M
The planned purchase would allow Embecta to serve patients outside of diabetes care.
We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated
Despite posting healthy earnings, Embecta Corp.'s ( NASDAQ:EMBC ) stock has been quite weak. Our analysis suggests that...
Embecta (NASDAQ:EMBC) Is Paying Out A Dividend Of $0.15
The board of Embecta Corp. ( NASDAQ:EMBC ) has announced that it will pay a dividend of $0.15 per share on the 17th of...
3 Healthcare Stocks Paying the Highest Dividends of 2026
Which of the highest-yielding healthcare stocks are value traps or golden opportunities?